Chatbot support to reduce chemsex and HIV risk for gay and bisexual men
Part of Infections, Mental health clinical trials.
This study tests a chatbot that gives support and information to help men who have sex with men reduce chemsex (using drugs during sex) and lower their HIV risk. It might help you make safer choices and connect with support.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man living in Hong Kong and at least 18 years old.
- You can understand Cantonese.
- You've had anal sex with at least one man in the past 6 months.
- You're willing to give your contact information for follow-up.
- You have access to WhatsApp.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a smartphone chatbot that teaches mindfulness-based stress management to help men who have sex with men in China reduce stress and improve mental health. Participants use the chatbot and check in over time to see if it helps.
This study explores ways to support men who have sex with men (MSM) in Bangkok who use drugs during sexual activities, called 'chemsex.' Researchers want to understand how community leaders, healthcare workers, and police can work together to keep people safer and healthier.
This study tests whether daily text messages can help reduce drinking and lower HIV risk. It is for men who have sex with men and who drink heavily, and uses simple text check-ins to support healthier choices.
This trial tests a mobile app designed to help young men who have sex with men (and non-binary people assigned male at birth) reduce their risk of HIV. It's for people who are HIV-negative or don't know their status, and who have had anal sex with a partner with a penis in the last year.
This study follows young men who have sex with men and use drugs during sex (chemsex) to understand their health and behaviors. It aims to provide better care and support.
This study tests a chatbot that gives you information and support to help you start or stay on PrEP, a daily pill that prevents HIV. It's for Black men in the Southern U.S. who might be at higher risk.
Hear when a new Behavior trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.